Shionogi & Co. submits LoI to Kenyan ministry of health to introduce cefiderocol for treatment of serious gram-negative bacterial infections (¥2515.0000, -0.5)
StreetAccount Sector Summary - Healthcare Post-Market
ViiV Healthcare reports on data presented at IAS 2025
ViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV treatment (1411.5000p, +3)
StreetAccount Sector Summary - Healthcare Pre-Market
StreetAccount Sector Summary - Healthcare Weekly Recap
StreetAccount Summary: Notable Drug Events expected for the week of 13-Jul
CEOLIA to take over from Shionogi as promotional partner for Stallergenes Greer's Actair in Japan for allergic rhinitis (¥2500.5000, 0)
BioVersys and Shionogi enter Into global research collaboration; BioVersys to receive CHF 5.0M upfront payment (CHF 34.60, 0.00)
StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (91 total)
Powered by FactSet Research Systems Inc.